Belgian Science Day 2024
GLIOMATCH project coordinator, Prof Frederik de Smet, held a lecture about how immunotherapy can be harnessed for brain cancer research.
July 2024 is Glioblastoma Awareness Month
Glioblastoma Awareness Day (GBM Day) on 17 July 2024 aimed to raise awareness and support for those affected by glioblastoma, an aggressive brain tumour. GLIOMATCH’s month-long campaign is summarised in this article, highlighting the critical need for further research.
GLIOMATCH project kick-off meeting takes place in Leuven, Belgium
The GLIOMATCH project kick-off meeting took place from 25-27 March 2024 and was hosted by KU Leuven, the project coordinator, at the Faculty Club in Leuven, Belgium. This marks the first in-person gathering of the project’s 14 partner institutions.
GLIOMATCH: Pioneering personalised therapies for malignant glioma, a devastating brain cancer
According to the World Health Organisation, cancer ranks as the world’s second-leading cause of death. Brain tumours have particularly high mortality rates. The GLIOMATCH project is set to rewrite this narrative.
The GLIOMATCH project has officially started in January 2024
Under the coordination of KU Leuven, the multidisciplinary consortium will be working on pioneering personalised therapies for brain cancer patients.
GLIOMATCH selected for Horizon Europe funding
The GLIOMATCH project aimed at advancing precision medicine for brain cancer patients has received a total funding of €12.59 million from the EU, Switzerland, and the UK.